Reply: Opioid Toxicity in Inflammatory Bowel Disease Patients Likely Includes Direct Enterocyte Effects That Exacerbate Disease

Subramanian, V orcid.org/0000-0003-3603-0861, Burr, NE orcid.org/0000-0003-1988-2982 and Hull, MA orcid.org/0000-0001-7414-1576 (2018) Reply: Opioid Toxicity in Inflammatory Bowel Disease Patients Likely Includes Direct Enterocyte Effects That Exacerbate Disease. Clinical Gastroenterology and Hepatology, 16 (10). pp. 1680-1681. ISSN 1542-3565

Metadata

Authors/Creators:
Commentary on: Burr, NE orcid.org/0000-0003-1988-2982, Smith, C orcid.org/0000-0002-0184-3590, West, R orcid.org/0000-0001-7305-3654 et al. (2 more authors) (2018) Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England. Clinical Gastroenterology and Hepatology, 16 (4). 534-541.e6. ISSN 1542-3565
Copyright, Publisher and Additional Information: © 2018 by the AGA Institute. All rights reserved. This is an author produced version of a paper published in Clinical Gastroenterology and Hepatology. Uploaded in accordance with the publisher's self-archiving policy
Dates:
  • Published: October 2018
  • Published (online): 2 July 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Funding Information:
FunderGrant number
Leeds Teaching Hospitals Charitable Foundation9R01/14-04
Crohns and Colitis UKm16-4
Depositing User: Symplectic Publications
Date Deposited: 25 Oct 2018 11:53
Last Modified: 02 Jul 2019 00:42
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.cgh.2018.06.006

Commentary/Response Threads

Share / Export

Statistics